Follow
Susana Lêdo
Susana Lêdo
Investigadora, i3S, Centro de Genética Preventiva e Preditiva (CGPP), Universidade do Porto
Verified email at iucs.cespu.pt
Title
Cited by
Cited by
Year
Psychological aspects of pre‐symptomatic testing for Machado–Joseph disease and familial amyloid polyneuropathy type I
L Rolim, Â Leite, S Ledo, M Paneque, J Sequeiros, M Fleming
Clinical genetics 69 (4), 297-305, 2006
582006
Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans
Games Collaborative Group
Journal of Neuroimmunology 179 (1-2), 108-116, 2006
352006
Prenatal diagnosis of Machado–Joseph disease by direct mutation analysis
J Sequeiros, P Maciel, F Taborda, S Lêdo, JC Rocha, A Lopes, F Reto, ...
Prenatal Diagnosis: Published in Affiliation With the International Society …, 1998
321998
Twenty years of a pre-symptomatic testing protocol for late-onset neurological diseases in Portugal
M Paneque, J Félix, Á Mendes, C Lemos, S Lêdo, J Silva, J Sequeiros
Acta Medica Portuguesa, vol. 32 (4), p. 295-304, 2019
192019
Mid-and long-term anxiety levels associated with presymptomatic testing of Huntington’s disease, Machado-Joseph disease, and familial amyloid polyneuropathy
S Lêdo, Â Leite, T Souto, MA Dinis, J Sequeiros
Brazilian Journal of Psychiatry 38, 113-120, 2016
152016
Predictive testing for two neurodegenerative disorders (FAP and HD): a psychological point of view
L Susana, P Milena, R José, S Jorge
Open Journal of Genetics 3 (04), 270, 2013
142013
Long-term predictors for psychological outcome of pre-symptomatic testing for late-onset neurological diseases
S Lêdo, A Ramires, Â Leite, MAP Dinis, J Sequeiros
European journal of medical genetics 61 (10), 575-580, 2018
102018
Anxiety and pre-symptomatic testing for neurodegenerative disorders
L Susana, J Sequeiros
Open Journal of Genetics 3 (02), 14, 2013
92013
Ten years of a programme for presymptomatic testing (PST) and prenatal diagnosis (PND) in late-onset neurological diseases in Portugal: Machado-Joseph disease (MJD), Huntington …
J Sequeiros, J Pinto-Basto, T Coelho, J Rocha, S Lêdo, Â Leite
European journal of Human Genetics 14, 1-1, 2006
82006
Depression as the middle-and long-term impact for pre-symptomatic testing of late-onset neurodegenerative disorders
S Lêdo, A Leite, T Souto, MAP Dinis, J Sequeiros
Temas em Psicologia 24 (2), 579-594, 2016
72016
Depression levels in Pre-symptomatic Testing for Neurodegenerative Diseases: a psychological point of view
S Lêdo, A Leite, J Sequeiros
Journal of Life Medicine 2 (2), 39-50, 2014
62014
Impacto psicológico do teste pré-sintomático na doença de Machado-Joseph. Resultados preliminares
M Fleming, S Leˆdo, JC Rocha, J Sequeiros
Arquivos de Medicina 18 (1/2), 72-75, 2004
62004
Long-term Negative Psychological Impact of Presymptomatic Testing for Huntington’s disease
ÂMT Leite, MAP Dinis, SMLS Pinto, AMBC Pinto, AIP Gomes, HFP Sousa
Journal of Health, Medicine and Nursing 34, 1-9, 2017
22017
Pre-symptomatic testing for neurodegenerative disorders: Middle-to long-term psychopathological impact
S Lêdo, Â Leite, T Souto, MAP Dinis, J Sequeiros
Psicothema 29 (4), 446-452, 2017
12017
Familial 18p syndrome--a clinical case
C Laranjeira, A Fortuna, A Teixeira, N Teles, S Peres
Anales de Pediatria (Barcelona, Spain: 2003) 70 (1), 89-90, 2008
12008
Susana Lêdo, Ana Ramires 2, Ângela Leite 2, Maria Alzira P. Dinis 3, Jorge Sequeiros
S Lêdo
2017
La depresión como el indicador de impacto psicológico a la media y largo plazo de la prueba pre-sintomática para enfermedades de aparición tardía
S Lêdo, A Leite, T Souto, MAP Dinis, J Sequeiros
Temas em Psicologia 24 (2), 579-594, 2016
2016
Ataxie avec apraxie oculomotrice de type 2 (AOA2): étude clinique, biologique et corrélation génotype/phénotype d'une cohorte de 90 patients
M Anheim, B Monga, M Fleury, P Charles, C Barbot, M Salih, JP Delaunoy, ...
Revue Neurologique 166 (1), S14, 2010
2010
Author Index Vol. 13, No. 7–8, 2010
KD Christensen, TE Jayaratne, P Javaher, E Nyoungui, L Ioannou, ...
Public Health Genomics 13 (7-8), 544-544, 2010
2010
Maxia with oculomotor apraxia type 2 (AOA2): Clinical and molecular delineation, genotype to phenotype correlations and strategy for diagnosis
M Anheim, M Fleury, P Charles, C Barbot, M Salih, JP Delaunoy, L Arning, ...
MOVEMENT DISORDERS 24, S135-S135, 2009
2009
The system can't perform the operation now. Try again later.
Articles 1–20